High Pointe Capital Management’s Allergan plc AGN Stock Holding History

High Pointe Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,390	Closed	-$2.37M	–	96
2019 Q4	$2.37M	Sell	12,390 -60	-0.5%	-$10.8K	2.81%	7
2019 Q3	$2.1M	Sell	12,450 -70	-0.6%	-$11.4K	2.87%	6
2019 Q2	$2.1M	Buy	12,520 +2,360	+23%	+$327K	2.94%	6
2019 Q1	$1.49M	Buy	10,160 +1,410	+16%	+$204K	2.04%	9
2018 Q4	$1.17M	Buy	8,750 +2,430	+38%	+$398K	1.93%	17
2018 Q3	$1.2M	Buy	6,320 +1,210	+24%	+$222K	1.62%	30
2018 Q2	$852K	Hold	5,110	–	–	1.21%	36
2018 Q1	$860K	Buy	+5,110	New	+$857K	1.18%	36
2015 Q1	–	Sell	-2,670	Closed	-$687K	–	176
2014 Q4	$687K	Hold	2,670	–	–	0.3%	117
2014 Q3	$644K	Buy	+2,670	New	+$598K	0.28%	125

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

High Pointe Capital Management's AGN Position: Q1 2020 in Review

High Pointe Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 12,390 shares — an estimated $2.37M sold.

High Pointe Capital Management first reported a position in AGN in Q3 2014 and held it in 10 quarters. The position peaked at $2.37M in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

High Pointe Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
High Pointe Capital Management sold 12,390 Allergan plc shares in Q1 2020, an estimated $2.37M.
High Pointe Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 10 quarters.
High Pointe Capital Management's Allergan plc position peaked at $2.37M in Q4 2019.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on High Pointe Capital Management's 13F filing for Q1 2020, filed 12 May 2020.